Oxford Covid-19 vaccine trial shows positive results- report published

News Desk-  The preliminary results of the phase I/II trial of Oxford Covid-19 vaccine, just published in The Lancet journal, involved 1,107 healthy adults, and found that the vaccine induced an immune response both via antibodies and the T cells of the immune system up to day 56 of the ongoing trial.

Medical experts in India on Monday hailed the results of Oxford University’s early-stage human trials for a Covid-19 vaccine, with some saying it’s the “most scientifically done” among all such exercises, while others expressing hope that the final trials will “bear fruit”.

The plan and design of the trials and the whole logistics and demographic range of volunteers from 18-55 years has been “done the most scientifically” among all the trials going on globally.

The trial data of a Covid-19 vaccine developed by AstraZeneca and Oxford University reveals that it is safe and induces immune response, with mild side effects in some participants, which the scientists say can be treated with the commonly available pain medication paracetamol.

The preliminary results of the phase I/II trial, just published in The Lancet journal, involved 1,107 healthy adults, and found that the vaccine induced an immune response both via antibodies and the T cells of the immune system up to day 56 of the ongoing trial.

Since emerging in the central Chinese city of Wuhan last year, the virus has has killed over 606,000 people and infected more than 14,538,000 people worldwide. In India, the virus has caused 27,497 deaths and infected over 1.1 million people, according to latest official figures.